U.S. markets open in 46 minutes
  • S&P Futures

    3,847.00
    +37.75 (+0.99%)
     
  • Dow Futures

    31,228.00
    +316.00 (+1.02%)
     
  • Nasdaq Futures

    13,045.25
    +134.25 (+1.04%)
     
  • Russell 2000 Futures

    2,238.00
    +38.80 (+1.76%)
     
  • Crude Oil

    61.88
    +0.38 (+0.62%)
     
  • Gold

    1,729.00
    +0.20 (+0.01%)
     
  • Silver

    26.85
    +0.41 (+1.55%)
     
  • EUR/USD

    1.2050
    -0.0038 (-0.31%)
     
  • 10-Yr Bond

    1.4530
    -0.0070 (-0.48%)
     
  • Vix

    24.95
    -3.94 (-13.64%)
     
  • GBP/USD

    1.3920
    -0.0002 (-0.01%)
     
  • USD/JPY

    106.7330
    +0.2310 (+0.22%)
     
  • BTC-USD

    48,000.96
    +3,197.14 (+7.14%)
     
  • CMC Crypto 200

    964.16
    +31.03 (+3.33%)
     
  • FTSE 100

    6,570.19
    +86.76 (+1.34%)
     
  • Nikkei 225

    29,663.50
    +697.49 (+2.41%)
     

BD Board Declares Dividend

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

FRANKLIN LAKES, N.J., Jan. 25, 2021 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payable on March 31, 2021 to holders of record on March 10, 2021. The indicated annual dividend rate is $3.32 per share.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.

Contact:
Kristen M. Stewart, CFA, Investor Relations – 201-847-5378
Troy Kirkpatrick, Communications – 858-617-2361

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/bd-board-declares-dividend-301214378.html

SOURCE BD (Becton, Dickinson and Company)